About Ingeny
Ingeny is a company based in Goes (Netherlands) founded in 2013. It operates as a B2B. Ingeny operates in a competitive market with competitors including GenMark Diagnostics, Stilla Technologies, Silicon Biosystems, Sense Biodetection and Mesa Biotech, among others.
- Headquarter Goes, Netherlands
- SectorsHealthcare
- Website ingeny.com
- Investors
Funding Insights of Ingeny
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Ingeny with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2013 | – | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Ingeny
Ingeny has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Startupbootcamp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech focused global accelerator firm | – | startupbootcamp.org | London, United Kingdom |
Investor details for Ingeny
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ingeny
2 dated milestones of Ingeny, from founding to its latest funding, stage changes and deals.
- Founded Ingeny is founded.
- Funding First funding round.
Competitors of Ingeny
Ingeny operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenMark Diagnostics, Stilla Technologies, Silicon Biosystems, Sense Biodetection and Mesa Biotech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genmarkdx.com | 1993 | San Diego, United States | $8.56M | 797 | Instruments and test panels for multiplexed molecular diagnostics are provided. | |
| stillatechnologies.com | 2013 | Villejuif, France | $53.11M | – | Digital PCR solutions for research are developed and analyzed. | |
| siliconbiosystems.com | 1999 | Bologna, Italy | $25.53M | – | Lab-on-a-chip technologies for miniaturized cell-biology testing are developed. | |
| sense-bio.com | 2014 | Abingdon, United Kingdom | $79.22M | 43 | Provider of point of care molecular diagnostics solutions | |
| mesabiotech.com | 2009 | San Diego, United States | $26.8M | 131 | Point-of-care molecular diagnostic kits are developed and supplied. | |
| quantalife.com | 2008 | Pleasanton, United States | $28.71M | – | Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. | |
| helixis.com | 2007 | Carlsbad, United States | $17.33M | – | Nucleic-acid analysis instruments were developed for research and clinical applications. | |
| dnae.com | 2003 | London, United Kingdom | – | 111 | Semi-conductor-based NGS diagnostics for infectious diseases are offered. | |
| readygotest.com | 2020 | Bath, United Kingdom | $3.89M | – | Provider of diagnostic test and sample collection tools for research labs | |
| minipcr.com | 2013 | Cambridge, United States | – | 18 | PCR and electrophoresis instruments are developed for laboratory use. |
Detailed competitors of Ingeny
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ingeny
The website of Ingeny (ingeny.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Ingeny. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Ingeny
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Ingeny
Complete news archive for Ingeny
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Ingeny
10 companies that operate in the same segment as Ingeny (Clinical Genomics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Panomic profiling technologies are developed for cancer precision medicine. | 1996 | Irving, Texas, United States | USD 1.23 B | – | 1,339 | |
Genomics-based diagnostic tests for cancer are provided. | 2010 | Cambridge, Massachusetts, United States | USD 96.5 M | – | – | |
Digital molecular biology analytics are developed for disease management. | 2012 | Carlsbad, California, United States | USD 95.02 M | – | 46 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Genomic database for clinical research is provided. | 2015 | San Francisco, California, United States | USD 435 M | – | – | |
Genomic sequencing and diagnosis software is provided for healthcare. | 2011 | Menlo Park, California, United States | USD 87.3 M | USD 69.65 M | 229 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ingeny
Ingeny was founded in 2013.
Ingeny is headquartered in Goes, Netherlands. It is registered at Goes, Zeeland, Netherlands.
Ingeny, established in 2013 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, dna analysis, and diagnostic technology. Offers advanced technology for ultra-fast DNA analysis, serving scientific and medical sectors. Adapting to market demands with innovation and client-focused strategies.
Ingeny's top competitors include GenMark Diagnostics, Stilla Technologies and Silicon Biosystems.
Ingeny has 1 investor. Key investors include Startupbootcamp.
The website of Ingeny receives about 681 thousand visits a month.